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Background:
 
 Acute myocarditis (AM) is a rare and potentially lethal con-
dition for which diagnosis and treatment remain challenging. The recent H1N1
flu pandemic was an opportunity to improve our knowledge about this patho-
logy.
 
Methods:
 
 Since October 2009, we have prospectively enrolled patients
diagnosed with AM from intensive care units and cardiology departments in
France using the following criteria : anatomo-pathological proof of AM OR
presence of infectious context and >1 cardiac symptom and abnormal troponin
level and abnormal ECG, echo or cardiac MRI and absence of significant
coronary artery disease.
 
Results:
 
 71 patients (59 male, mean age 39±20) have been enrolled. Pre-
senting symptoms were chest pain (77,5%), dyspnea (33,8%), cardiogenic
shock (11,3%) and conduction disorder or significant arrhythmia (8,4%). ST
segment or T wave changes were present in 88,7%. Mean troponin and CRP
levels were 9,1±9,8 
 
μ
 
g/l and 56±59 mg/l, respectively. Echocardiography
showed a mean ejection fraction of 51±15%, wall motion abnormalities in
39%, and pericardial effusion in 18%. In 62% of cases, cardiac MRI was per-
formed showing oedema (43%) and late enhancement (68%). Only 3 patients
underwent a biopsy. Complications were congestive heart failure (22,5%) and
ventricular arrhythmia (7%). Two patients died before hospital discharge.
Viral origin of the AM was proven or presumed in 83% of patients, including
4 diagnosed with H1N1 flu. Treatment generally included beta-blockers, ACE
inhibitors and aspirin.
 
Conclusion:
 
 AM affects mainly young patients whose prognosis may be
compromised by severe complications. Follow-up of this registry will provide
insight into the prognosis and the long-term impact of medical therapy. 
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Background:
 
 Heart rate recovery (HRR) prognostic value is well esta-
blished in patients with coronary artery disease but poorly documented in
patients with heart failure (HF) and not established in those with advanced HF. 
 
Methods:
 
 144 patients with compensated HF underwent cardiopulmonary
exercise testing (CPX) and were followed for a combined death/ transplanta-
tion/ hospitalization end point. Patients with advanced HF were defined as
those with peak VO2
 
≤
 
 14ml/kg/mn (n= 41/144; 28%). Mean age and left ven-
tricular ejection fraction (LVEF) were 53±12 years and 29±7% respectively in
all population and 58±11 years and 28±7% respectively in the advanced HF
group. Ninety one percent of patients received betablockers (93% in advanced
HF group). HRR at 1-minute post-CPX was calculated as the difference
between heart rate at peak exercise and after 1 minute of active recovery. 
 
Results:
 
 Among the 144 patients, we recorded 10 mortality, 7 cardiac
transplantation and 8 hospitalization for acute HF outcome events over 16
months of follow-up. The baseline mean peak respiratory exchange ratio
(RER), peak VO2, VE/VCO2 slope, and HRR1 were 1.13±0.09, 16±4 ml/kg/
mn, 35±8, 13±12 beat/mn, respectively. Although LVEF, peak VO2, VE/
VCO2 slope and HRR1 were significant univariate predictors of the composite
end point (p<0.05), multivariate Cox regression analysis only retained LVEF
(chi2 = 5.5, p=0.01) and HRR1 (chi2 = 5.2, p= 0.02) in the equation. In the
group of patients with advanced HF the mean peak RER, peak VO2, VE/
VCO2 slope, and HRR1 were 1.10±0.07, 12±1 ml/kg/mn, 39±11, 9±8 beat/
mn, respectively. Kaplan-Meier analysis revealed a significant difference in
survival according to a 5 bpm HRR1 threshold: 68% in patients with HRR1
 
≤
 
5 bpm vs 96% in those with HRR1> 5bpm (logrank=5, p=0.02) (HR= 2.66;
CI: 2.08-2.66, p=0.02). 
 
Conclusions:
 
 HRR is an easily measured noninvasive variable that can be
used to further prognostically risk stratify patients with advanced HF. 
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Background:
 
 Patients with heart failure (HF) and peak oxygen consump-
tion (pVO2) < 10 ml/kg/mn have a very poor prognosis whereas those with a
pVO2 >18 ml/kg/mn have a very good prognosis. However, there remains a
“grey zone” of intermediate pVO2 values between 10 and 18ml/kg/mn which
needs to be further stratified. The aim of the study is to evaluate whether
patients with intermediate pVO2 values can be more accurately assessed in
terms of prognosis using heart rate recovery (HRR). 
 
Methods:
 
 92 patients with compensated HF with 10< pVO2
 
≤
 
 18ml/kg/mn
at cardiopulmonary exercise testing (CPX) were followed for a combined
death/ transplantation/ hospitalisation end point. Mean age and left ventricular
ejection fraction (LVEF) were 54±12 years and 30±6% respectively. Ninety
one percent of patients received betablockers. Heart rate at 1-minute post-CPX
(HRR1) was calculated as the difference between heart rate at peak exercise
and after 1 minute of active recovery. 
 
Results:
 
 We recorded 5 mortality, 4 cardiac transplantation and 5 hospita-
lisation for acute HF outcome events over 16 months of follow-up. The base-
line mean peak respiratory exchange ratio (RER), pVO2, minute ventilation/
carbon dioxide production (VE/VCO2) slope, and HRR1 were 1.14±0.10,
14.7±2.0 ml/kg/mn, 36.6±8.5, 12±13 beat/mn respectively. Although LVEF,
VE/VCO2 slope and HRR1 were significant univariate predictors of the com-
posite end point (p<0.01), multivariate Cox regression analysis only retained
the HRR1 in the equation (chi2 = 5.07, HR= 2.39, CI: 2.19-2.68, p= 0.02).
Kaplan-Meier analysis revealed a significant difference in event-free survival
according to a 7 bpm HRR1 cut-off: 65 % in patients with HRR1
 
≤
 
 7 bpm vs
96% in those with HRR1> 7 bpm (logrank=14, p=0.0002) (HR= 2.53; CI:
2.42-2.65, p=0.003).
 
Conclusions:
 
 HRR1 is an easily measured noninvasive variable that can be
used to further prognostically risk stratify patients with HF and intermediate
peak oxygen consumption (10< pVO2
 
≤
 
 18ml/kg/mn).
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Objectives:
 
 To investigate the impact of LV dyssynchrony on exercise
capacity in patients with hypertrophic cardiomyopathy (HCM) and preserved
left ventricular ejection fraction (LVEF>50%).
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Methods:
 
 The study included 31 patients (57±14 years, 23 males) with
HCM and preserved LVEF (65±8%, range 50 to 79%) without significant LV
obstruction (<50mmHg) at rest. All underwent exercise testing and 2D and 3D
echocardiography. LV dyssynchrony defined by the 16 segment standard
deviation of time to peak longitudinal strain by speckle tracking (16SD) was
compared to exercise capacity, 3D myocardial mass and LV filling pressure
assessed by the ratio E/E’
 
TDI
 
 (Peak early filling velocity over peak systolic
velocity by TDI).
 
Results:
 
 LV dyssynchrony (16SD=96±35 ms) was associated to a reduced
exercise capacity (r=-0.39, p=0.035) and increased LV filling pressure (r=0.50,
p=0.01). Interestingly LV dyssynchrony increased with the severity of myo-
cardial hypertrophy (r=0.66, p<0.001) and was associated to a reduce global-
strain (r=0.62, p<0.001). 
 
Conclusion:
 
 Myocardial dyssynchrony increased with the severity of myo-
cardial hypertrophy in HCM patients and may be involved in exercise limita-
tion in patients without LV obstruction and preserved LVEF. 
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Background:
 
 Obesity has been described as an independent risk factor for
heart failure (HF). However, B-type natriuretic peptide (BNP) failed in evalua-
tion of the severity of HF in obese patient because: i) Obese patients suffer
dyspnoea earlier than non obese which leads to an earlier diagnosis an could
explain lower BNP rates, and ii) BNP receptors were found on adipocytes sug-
gesting a higher clearance of BNP in obese patients. 
 
Purpose:
 
 Our aim was to explore the relationship between functional status
of obese HF patients and BNP levels. 
 
Method and results:
 
 In our HF registry, 249 patients with dilated cardio-
myopathy (DCM) were included in 3 groups regarding their body mass index:
112 normal weighted <25 kg/m
 
2
 
 (NW), 88 overweighted 25-29.9 kg/m
 
2
 
 (OW),
and 49 obese 30 kg/m
 
2
 
 or greater (Ob) patients. We analyzed NYHA status,
the 6 minutes walk test (6MWT) a simple and reliable way to assess the exer-
cise capacity of DCM patients, and measured the peak oxygen consumption
during incremental exercise (VO2 max). 
There was no significant difference between the 3 groups for baseline cha-
racteristics and ejection fraction was comparable (NW: 27+/-9%; OW: 27+/-
9%; Ob: 29+/-10%; p=0.26))
BNP levels were lower in the obese group (962+/-1166 in NW, 757+/-204
in OW, 353+/-608 in Ob; p=0.02). There was no significant difference
between groups in distance covered in the 6MWT (NW: 370+/-98m; OW:
392+/-125m; Ob: 388m; p=0.27) and NYHA scores (NM: 2.3+/-0.7; OW:
2.3+/-0.6; Ob: 2.4+/-0.7; p=0.32), however, VO2 max was significantly lower
in the Ob patients (NW: 17.4+/-7.7 ml/min/kg; OW: 16.1+/-5.0 ml/min/kg;
Ob: 14.8+/-6.9ml/min/kg; p=0.04). 
 
Conclusion:
 
 These results show that VO2 max is more useful to discrimi-
nate functional status in obese patients with DCM compared to 6MWT,
NYHA scores and BNP levels. BNP in the obese likely underestimates seve-
rity of HF.
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Purpose:
 
 Heart rate adjustment of exercise-induced ST-segment depres-
sion (ST/HR index and ST/HR hysteresis) has been suggested as an accurate
predictor of the presence of a coronary artery disease. Its powerful predictive
value for proven coronary artery stenosis is now accepted. The objective of
our study was to investigate the sentitivity and specificity of computerized ST/
HR index and ST/HR hysteresis to detect significant ischemia. 
 
Methods: We used a cross-sectional analysis of exercise test and myocar-
dial perfusion stress-rest SPECT data. The study population comprised 710
consecutive patients referred for myocardial perfusion imaging. The threshold
of significant ischemia was set above 10% reversibility hypoperfusion area
from entire surface of left ventricle using gated -SPECT image analysis
(QGS). Diagnostic performance of ST/HR index and ST/HR hysteresis was
assessed by receiver operating characteristic (ROC) curve. 
Results: Crude ST/HR hysteresis showed at the same 70% specificity, a
sensitivities of 56% and 57%, respectively. Diagnostic performance of ST/HR
hysteresis seems slightly better than ST/HR index (AUC= .668 vs .654) with
the following cut points .038 mV and 1.625 µV/ bpm. Adjusting these varia-
bles to body mass index does not improve the diagnostic performance. Com-
bining an independant clinical judgement in the model yields a moderate
increase of the diagnostic accuracy the prediction only for ST/HR index as
suggested by the AUC (.688) . 
Conclusions: ST/HR index and ST/HR hysteresis have a good capability to
detect a significant myocardial ischemia evaluated by SPECT, which has the-
rapeutic implications. 
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Introduction: Heart failure (HF) remains a frequent reason for admission
and readmission to hospital and therefore represents a major public health
burden. The aim of our study is to report the experience of our therapeutic unit
of heart failure (TUHF), the epidemiological profile, the management and the
outcome of 1200 patients with chronic heart failure (CHF).
Material and methods: The study included 1200 patients, admitted in the
TUHF from May 2006 to February 2010. We included all patients with (CHF)
symptomatic class II, III, or IV. All patients were evaluated clinically with
monitoring of blood pressure , 6 min walk test and electrocardiogram. Two-
dimensional echocardiography and laboratory tests were performed in all
patients. 
Results: The mean age of our patients was 64.82±12.14 years (16-100),
75% were men. Hypertension was the most frequently cardiovascular risk
factor (26%) followed by smoking (22%) and diabetes (21%). Patients were
mainly in NYHA class II ( 58%), and 27% were in NYHA class III. The ave-
rage of 6 minute walk test was 121.36 ±92.74 m (10 – 630 ). The mean heart
rate at admission was 81.13 ± 17.24 bpm. More than half of our patients had
an LVEF <35% (56.91%), 31.33% had LVEF between 35-50%, and 6.33%
had an LVEF> 50%. Ischemic (55.67%) and hypertensive heart disease
(2.67%) remain the two most frequent etiology. 
Regarding treatment; 78.33% of our patients were treated with beta-blockers,
89.08%with Angiotensin-converting enzyme inhibitors (ACEI), 50.75% with
spironolactone , and 12.75% with diuretics. Resynchronization has been per-
formed in two patients. 
The optimal medical treatment has allowed a significant improvement in
NYHA functional class: NYHA class II (20% vs. 58%, P= 0.037), NYHA
class III (5% vs 27%, P= 0.002), a significant improvement in test 6min walk
( 121.36 vs 465.66 m, P= 0.0001), and a significant reduction in heart rate
from 80.13 bpm to 63.12bpm (P< 0.05) on an average of 6.82± 4.18 months.
Conclusion: The creating of TUHF in our department has allowed an
improving of the quality of care and an optimization of the treatment.
